Factors influencing long-term survival in patients with T3 gallbladder adenocarcinoma

Digestion

Volumn 79, Issue 3, 2009, Pages 151-157

  Chakravarty, K Dilip ^a   Yeh, Chun Nan ^a,b   Jan, Yi Yin ^a,b   Chen, Miin Fu ^a,b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Carcinoembryonic antigen; Gallbladder adenocarcinoma; Prognosis; Resection margin; Tumor marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CHOLECYSTECTOMY; DEMOGRAPHY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TAIWAN;

ADENOCARCINOMA; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 62949113284     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210131     Document Type: Article

References (28)

1. North JH, Pack MS, Hong C, et al: Prognostic factors for adenocarcinoma of the gallbladder: an analysis of 162 cases. Am Surg 1998; 64: 437-440.
2. Silk YN, Douglass HO, Nava HR, et al: Carcinoma of the gallbladder: the Roswell Park experience. Ann Surg 1989; 210: 751-757.
3. Wakai T, Shirai Y, Yokoyama N, et al: Early gallbladder carcinoma does not warrant radical resection. Br J Surg 2001; 88: 675-678.
4. Shirai Y, Yoshida K, Tsukada K, et al: Early carcinoma of the gallbladder. Eur J Surg 1992; 158: 545-548.
5. Fong Y: Treatment of T2 gallbladder cancer. Ann Surg Oncol 2003; 10: 490.
6. Aramaki M, Matsumoto T, Shibata K, et al: Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma. Hepatogastroenterology 2004; 51: 1609-1611.
7. Shirai Y, Yoshida K, Tsukada K, et al: Radical surgery for gallbladder carcinoma: long- term results. Ann Surg 1992; 216: 565-568.
8. Wakabayasi H, Ishimura K, Hashimoto N, et al: Analysis of prognostic factors after surgery for stage III and IV gallbladder cancer. Eur J Surg Oncol 2004; 88: 675-678.
9. Tsukada K, Hatakeyama K, Kurosaki I, et al: Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996; 120: 816-821.
10. Chijiiwa K, Noshiro H, Nakano K, et al: Role of surgery for GB carcinoma with special reference to lymph node metastasis and stage using western and Japanese classification systems. World J Surg 2000; 24: 1271-1276.
11. Shimada H, Endo I, Fujii Y, et al: Appraisal of surgical resection of gallbladder cancer with special reference to lymph node dissection. Langenbecks Arch Surg 2000; 385: 509-514.
12. Okamoto A, Tsuruta K, Ishiwata J, et al: Treatment of T3 and T4 carcinomas of the gallbladder. Int Surg 1996; 81: 130-135.
13. Norihiro K, Makuuchi M, Takeshi N, et al: Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 2003; 138: 741-750.
14. Yamaguchi K, Chijiiwa K, Saiki S, et al: Retrospective analysis of 70 operations for gall bladder carcinoma. Br J Surg 1997; 84: 200-204.
15. Roa I, Araya JC, Wistuba I, et al: Immuno- histochemical expression of the carcinoem- bryonic antigen in gallbladder cancer. Rev Med Chil 1991; 119: 129-136.
16. Benoist S, Panis Y, Fagniez PL: Long-term results after curative resection for carcinoma of the gallbladder: French University Association for Surgical Research. Am J Surg 1998; 175: 118-122.
17. Fong Y, Blumgart LH: Gallbladder cancer: comparison of patients presenting definitive operation with those after prior noncurative intervention. Ann Surg 2000; 232: 557-569.
18. Rios ZA, Sanchez BF, Garcia MJA, et al: Prognostic factors in gallbladder cancer. Gastroenterol Hepatol 2001; 24: 281-286.
19. Park JS, Yoon DS, Kim KS, et al: Analysis of prognostic factors after curative resection for gallbladder carcinoma. Korean J Gastroenterol 2006; 48: 32-36.
20. Wakai T, Shirai Y, Yokoyama N, et al: Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma. Ann Surg Oncol 2003; 10: 447-454.
21. Akdogan M, Parlak E, Kayhan B, et al: Are serum and biliary carcinoembryonic antigen and carbohydrate antigen 19-9 determinations reliable for differentiation between benign and malignant biliary disease. Turk J Gastroenterol 2003; 14: 181-184.
22. Maxwell P, Davis RI, Sloan JM: Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gall bladder, extrahe- patic bile ducts, and ampulla of Vater. J Pathol 1993; 170: 73-76.
23. Yeh CN, Jan YY, Chen MF: Hepatectomy for peripheral cholangiocarcinoma in elderly patients. Ann Surg Oncol 2006; 13: 1553-1559.
24. Pearlstone DB, Curley SA, Feig BW: The management of gallbladder cancer: before, during and after laparoscopic cholecystectomy. Semin Laparosc Surg 1998; 5: 121-128.
25. Toyonaga T, Chijiiwa K, Nakano K, et al: Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg 2003; 27: 266-271.
26. Goetze TO, Paolucci V: Benefits of reoperation of T2 gall bladder carcinoma: analysis of German registry. Ann Surg 2008; 247: 104-108.
27. Chijiiwa K, Nakano K, Tanaka M, et al: Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer. J Am Coll Surg 2001; 192: 600-607.
28. Muratore A, Polastri R, Bouzari H, et al: Radical surgery for gallbladder cancer: a worthwhile operation? Eur Surg Oncol 2000; 26:160-163. (Pubitemid 30242939)